Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 55,932 |
|
|||||
| News | - | ||||||
| Day High | 0.645049 | Low High |
|||||
| Day Low | 0.62 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Monopar Therapeutics Inc | MNPR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0295 | -4.49% | 0.6275 | 17:57:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.6401 | 0.62 | 0.645049 | 0.6275 | 0.657 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 173 | 55,932 | $ 0.6317169 | $ 35,333 | - | 0.2739 - 1.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:31:16 | 2 | $ 0.6201 | USD |
Monopar Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.37M | 14.87M | - | 0 | -8.4M | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Monopar Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNPR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.70 | 0.72 | 0.61 | 0.6561585 | 52,714 | -0.0725 | -10.36% |
| 1 Month | 0.701 | 0.85 | 0.4999 | 0.692866 | 180,906 | -0.0735 | -10.49% |
| 3 Months | 0.3356 | 1.73 | 0.309 | 1.01 | 5,865,555 | 0.2919 | 86.98% |
| 6 Months | 0.489 | 1.73 | 0.2739 | 0.926362 | 3,267,466 | 0.1385 | 28.32% |
| 1 Year | 1.19 | 1.75 | 0.2739 | 0.9286522 | 1,769,206 | -0.5625 | -47.27% |
| 3 Years | 5.84 | 6.98 | 0.2739 | 1.03 | 604,369 | -5.21 | -89.26% |
| 5 Years | 24.14 | 48.00 | 0.2739 | 1.63 | 447,611 | -23.51 | -97.40% |
Monopar Therapeutics Description
| Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. |
